Francisco Diaz-Mitoma
Affiliations: | University of Ottawa, Ottawa, ON, Canada |
Area:
Immunology, Microbiology Biology, PathologyGoogle:
"Francisco Diaz-Mitoma"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lassman AB, Reardon DA, Lee EQ, et al. (2019) Interim results of a phase I/IIa trial of a therapeutic CMV vaccine against recurrent glioblastoma (GBM). Journal of Clinical Oncology. 37: 2048-2048 |
| Vesikari T, Langley JM, Langley JM, et al. (2019) LB13. Trivalent Hepatitis B (HepB) Vaccine Yields Superior Seroprotection Rates in Adults: Results from the Phase 3 Double-Blind, Randomized Study Comparing Immunogenicity and Safety of a 3-Dose Regimen of Sci-B-Vac™ and Engerix B® (PROTECT) Open Forum Infectious Diseases. 6: S998-S998 |
| Anderson DE, Soare C, Ahmed T, et al. (2018) CMV gB/pp65 eVLPs formulated with GM-CSF as a therapeutic vaccine against CMV-positive tumors. Journal of Clinical Oncology. 36: e14032-e14032 |
| Gantt S, Quach C, Anderson DE, et al. (2018) LB18. An Enveloped Virus-like Particle (eVLP) Cytomegalovirus (CMV) Vaccine Is Immunogenic and Safe: Results of a First-in-Humans Study Open Forum Infectious Diseases. 5: S765-S765 |
| Iwamoto F, Diaz-Mitoma F, Anderson D, et al. (2018) ATIM-14. CMV gB/pp65 eVLPs FORMULATED WITH GM-CSF AS A THERAPEUTIC VACCINE AGAINST RECURRENT GLIOBLASTOMA (GBM) Neuro-Oncology. 20 |
| Anderson DE, Ahmed T, Soare C, et al. (2017) Use of CMV gB/pp65 eVLPs to harness the immunogenicity of foreign viral antigens to target solid tumors. Journal of Clinical Oncology. 35: 165-165 |
| Rivera R, Kang KH, Gardner MB, et al. (2016) Antibody responses to HIV-1 gp120 hypervariable regions in six long-term non-progressors American Journal of Infectious Diseases. 12: 38-45 |
| McNeil S, Shinde V, Andrew M, et al. (2014) Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014. Euro Surveillance : Bulletin Europã©En Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 19 |
| Halperin SA, Tapiéro B, Dionne M, et al. (2014) Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine. The Pediatric Infectious Disease Journal. 33: 73-80 |
| Tapiéro B, Halperin SA, Dionne M, et al. (2013) Safety and immunogenicity of a hexavalent vaccine administered at 2, 4 and 6 months of age with or without a heptavalent pneumococcal conjugate vaccine: a randomized, open-label study. The Pediatric Infectious Disease Journal. 32: 54-61 |